These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
6. Outbreak of Candida auris in Spain: A comparison of antifungal activity by three methods with published data. Ruiz-Gaitán AC; Cantón E; Fernández-Rivero ME; Ramírez P; Pemán J Int J Antimicrob Agents; 2019 May; 53(5):541-546. PubMed ID: 30769198 [TBL] [Abstract][Full Text] [Related]
7. Rezafungin Helleberg M; Jørgensen KM; Hare RK; Datcu R; Chowdhary A; Arendrup MC Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015032 [TBL] [Abstract][Full Text] [Related]
8. Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp. Pfaller MA; Castanheira M; Messer SA; Rhomberg PR; Jones RN Diagn Microbiol Infect Dis; 2014 Jun; 79(2):198-204. PubMed ID: 24736096 [TBL] [Abstract][Full Text] [Related]
9. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods. Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252 [TBL] [Abstract][Full Text] [Related]
10. Intra- and Interlaboratory Agreement in Assessing the In Vitro Activity of Micafungin against Common and Rare Candida Species with the EUCAST, CLSI, and Etest Methods. Meletiadis J; Geertsen E; Curfs-Breuker I; Meis JF; Mouton JW Antimicrob Agents Chemother; 2016 Oct; 60(10):6173-8. PubMed ID: 27480850 [TBL] [Abstract][Full Text] [Related]
11. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole. Espinel-Ingroff A; Barchiesi F; Cuenca-Estrella M; Pfaller MA; Rinaldi M; Rodriguez-Tudela JL; Verweij PE J Clin Microbiol; 2005 Aug; 43(8):3884-9. PubMed ID: 16081926 [TBL] [Abstract][Full Text] [Related]
12. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species. Pfaller MA; Castanheira M; Diekema DJ; Messer SA; Moet GJ; Jones RN J Clin Microbiol; 2010 May; 48(5):1592-9. PubMed ID: 20335424 [TBL] [Abstract][Full Text] [Related]
13. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method. Kathuria S; Singh PK; Sharma C; Prakash A; Masih A; Kumar A; Meis JF; Chowdhary A J Clin Microbiol; 2015 Jun; 53(6):1823-30. PubMed ID: 25809970 [TBL] [Abstract][Full Text] [Related]
14. Correlation between CLSI, EUCAST and Etest methodologies for amphotericin B and fluconazole antifungal susceptibility testing of Candida spp. clinical isolates. Claudino AL; Peixoto RF; Melhem MS; Szeszs MW; Lyon JP; Chavasco JK; Franco MC Pharmazie; 2008 Apr; 63(4):286-9. PubMed ID: 18468388 [TBL] [Abstract][Full Text] [Related]
15. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans. Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671 [TBL] [Abstract][Full Text] [Related]
16. EUCAST Susceptibility Testing of Isavuconazole: MIC Data for Contemporary Clinical Mold and Yeast Isolates. Jørgensen KM; Astvad KMT; Hare RK; Arendrup MC Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910898 [TBL] [Abstract][Full Text] [Related]
17. Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center. Marcos-Zambrano LJ; Escribano P; Sánchez C; Muñoz P; Bouza E; Guinea J Antimicrob Agents Chemother; 2014 Aug; 58(8):4565-72. PubMed ID: 24867979 [TBL] [Abstract][Full Text] [Related]
18. Etest and Sensititre YeastOne Susceptibility Testing of Echinocandins against Candida Species from a Single Center in Austria. Aigner M; Erbeznik T; Gschwentner M; Lass-Flörl C Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559257 [No Abstract] [Full Text] [Related]
19. [Comparison of Clinical Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution methods for determining the susceptibilities of Candida isolates]. Dalyan Cilo B; Topaç T; Ağca H; Sağlam S; Efe K; Ener B Mikrobiyol Bul; 2018 Jan; 52(1):35-48. PubMed ID: 29642828 [TBL] [Abstract][Full Text] [Related]
20. How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST). Arendrup MC; Friberg N; Mares M; Kahlmeter G; Meletiadis J; Guinea J; Clin Microbiol Infect; 2020 Nov; 26(11):1464-1472. PubMed ID: 32562861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]